Results and presentations


Latest results announcements and presentations


2016

2015

Majority stake investment in Acerta Pharma

2 Downloads available

Late-stage pipeline call

1 Download available

American College of Rheumatology (ACR) 2015 Investor science conference call

2 Downloads available

Acquisition of ZS Pharma

1 Download available

2014

European Society for Medical Oncology (ESMO) 2014

3 Downloads available

2013

2012

Fostamatinib analyst briefing

2 Downloads available

Fostamatinib analyst briefing video

Play Video

Naloxegol educational presentation

2 Downloads available

Naloxegol educational presentation video

Play Video

R&D Roundtable

1 Download available

30th Annual J.P. Morgan Healthcare Conference

1 Download available

Upcoming events

AstraZeneca Investor Science Event at ESMO 2017

Morgan Stanley healthcare conference


General Investor presentation

In our General Investor presentation, you will find up-to-date Investor information about our strategic priorities, our commitment to further focus our portfolio, our value-creation framework, our pipeline, news flow and more.

SEC filings

SEC filings are those documents that we are required to file by virtue of our listing on the New York Stock Exchange. They contain mainly financial information.

These documents are also available for viewing on the SEC website at www.sec.gov. The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA

 

 


Annual reports



Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Craig Marks

Finance, Fixed Income, M&A

Henry Wheeler

Oncology

Mitchell Chan

Oncology

Nick Stone

Respiratory, Brilinta

Christer Gruvris

Diabetes, Autoimmunity, Neuroscience & Infection

US general enquiries